Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.

Despite elimination efforts, the number of Mycobacterium leprae (M. leprae) infected individuals who develop leprosy, is still substantial. Solid evidence exists that individuals living in close proximity to patients are at increased risk to develop leprosy. Early diagnosis of leprosy in endemic are...

Full description

Bibliographic Details
Main Authors: Renate A Richardus, Konrad van der Zwet, Anouk van Hooij, Louis Wilson, Linda Oskam, Roel Faber, Susan J F van den Eeden, David Pahan, Khorshed Alam, Jan Hendrik Richardus, Annemieke Geluk
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-12-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC5746281?pdf=render
_version_ 1818235416589893632
author Renate A Richardus
Konrad van der Zwet
Anouk van Hooij
Louis Wilson
Linda Oskam
Roel Faber
Susan J F van den Eeden
David Pahan
Khorshed Alam
Jan Hendrik Richardus
Annemieke Geluk
author_facet Renate A Richardus
Konrad van der Zwet
Anouk van Hooij
Louis Wilson
Linda Oskam
Roel Faber
Susan J F van den Eeden
David Pahan
Khorshed Alam
Jan Hendrik Richardus
Annemieke Geluk
author_sort Renate A Richardus
collection DOAJ
description Despite elimination efforts, the number of Mycobacterium leprae (M. leprae) infected individuals who develop leprosy, is still substantial. Solid evidence exists that individuals living in close proximity to patients are at increased risk to develop leprosy. Early diagnosis of leprosy in endemic areas requires field-friendly tests that identify individuals at risk of developing the disease before clinical manifestation. Such assays will simultaneously contribute to reduction of current diagnostic delay as well as transmission. Antibody (Ab) levels directed against the M.leprae-specific phenolic glycolipid I (PGL-I) represents a surrogate marker for bacterial load. However, it is insufficiently defined whether anti-PGL-I antibodies can be utilized as prognostic biomarkers for disease in contacts. Particularly, in Bangladesh, where paucibacillary (PB) patients form the majority of leprosy cases, anti-PGL-I serology is an inadequate method for leprosy screening in contacts as a directive for prophylactic treatment.Between 2002 and 2009, fingerstick blood from leprosy patients' contacts without clinical signs of disease from a field-trial in Bangladesh was collected on filter paper at three time points covering six years of follow-up per person. Analysis of anti-PGL-I Ab levels for 25 contacts who developed leprosy during follow-up and 199 contacts who were not diagnosed with leprosy, was performed by ELISA after elution of bloodspots from filter paper.Anti-PGL-I Ab levels at intake did not significantly differ between contacts who developed leprosy during the study and those who remained free of disease. Moreover, anti-PGL-I serology was not prognostic in this population as no significant correlation was identified between anti-PGL-I Ab levels at intake and the onset of leprosy.In this highly endemic population in Bangladesh, no association was observed between anti-PGL-I Ab levels and onset of disease, urging the need for an extended, more specific biomarker signature for early detection of leprosy in this area.ClinicalTrials.gov ISRCTN61223447.
first_indexed 2024-12-12T11:53:37Z
format Article
id doaj.art-cfc307281b7e431c925774b057fc75ee
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-12-12T11:53:37Z
publishDate 2017-12-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-cfc307281b7e431c925774b057fc75ee2022-12-22T00:25:14ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352017-12-011112e000608310.1371/journal.pntd.0006083Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.Renate A RichardusKonrad van der ZwetAnouk van HooijLouis WilsonLinda OskamRoel FaberSusan J F van den EedenDavid PahanKhorshed AlamJan Hendrik RichardusAnnemieke GelukDespite elimination efforts, the number of Mycobacterium leprae (M. leprae) infected individuals who develop leprosy, is still substantial. Solid evidence exists that individuals living in close proximity to patients are at increased risk to develop leprosy. Early diagnosis of leprosy in endemic areas requires field-friendly tests that identify individuals at risk of developing the disease before clinical manifestation. Such assays will simultaneously contribute to reduction of current diagnostic delay as well as transmission. Antibody (Ab) levels directed against the M.leprae-specific phenolic glycolipid I (PGL-I) represents a surrogate marker for bacterial load. However, it is insufficiently defined whether anti-PGL-I antibodies can be utilized as prognostic biomarkers for disease in contacts. Particularly, in Bangladesh, where paucibacillary (PB) patients form the majority of leprosy cases, anti-PGL-I serology is an inadequate method for leprosy screening in contacts as a directive for prophylactic treatment.Between 2002 and 2009, fingerstick blood from leprosy patients' contacts without clinical signs of disease from a field-trial in Bangladesh was collected on filter paper at three time points covering six years of follow-up per person. Analysis of anti-PGL-I Ab levels for 25 contacts who developed leprosy during follow-up and 199 contacts who were not diagnosed with leprosy, was performed by ELISA after elution of bloodspots from filter paper.Anti-PGL-I Ab levels at intake did not significantly differ between contacts who developed leprosy during the study and those who remained free of disease. Moreover, anti-PGL-I serology was not prognostic in this population as no significant correlation was identified between anti-PGL-I Ab levels at intake and the onset of leprosy.In this highly endemic population in Bangladesh, no association was observed between anti-PGL-I Ab levels and onset of disease, urging the need for an extended, more specific biomarker signature for early detection of leprosy in this area.ClinicalTrials.gov ISRCTN61223447.http://europepmc.org/articles/PMC5746281?pdf=render
spellingShingle Renate A Richardus
Konrad van der Zwet
Anouk van Hooij
Louis Wilson
Linda Oskam
Roel Faber
Susan J F van den Eeden
David Pahan
Khorshed Alam
Jan Hendrik Richardus
Annemieke Geluk
Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.
PLoS Neglected Tropical Diseases
title Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.
title_full Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.
title_fullStr Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.
title_full_unstemmed Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.
title_short Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.
title_sort longitudinal assessment of anti pgl i serology in contacts of leprosy patients in bangladesh
url http://europepmc.org/articles/PMC5746281?pdf=render
work_keys_str_mv AT renatearichardus longitudinalassessmentofantipgliserologyincontactsofleprosypatientsinbangladesh
AT konradvanderzwet longitudinalassessmentofantipgliserologyincontactsofleprosypatientsinbangladesh
AT anoukvanhooij longitudinalassessmentofantipgliserologyincontactsofleprosypatientsinbangladesh
AT louiswilson longitudinalassessmentofantipgliserologyincontactsofleprosypatientsinbangladesh
AT lindaoskam longitudinalassessmentofantipgliserologyincontactsofleprosypatientsinbangladesh
AT roelfaber longitudinalassessmentofantipgliserologyincontactsofleprosypatientsinbangladesh
AT susanjfvandeneeden longitudinalassessmentofantipgliserologyincontactsofleprosypatientsinbangladesh
AT davidpahan longitudinalassessmentofantipgliserologyincontactsofleprosypatientsinbangladesh
AT khorshedalam longitudinalassessmentofantipgliserologyincontactsofleprosypatientsinbangladesh
AT janhendrikrichardus longitudinalassessmentofantipgliserologyincontactsofleprosypatientsinbangladesh
AT annemiekegeluk longitudinalassessmentofantipgliserologyincontactsofleprosypatientsinbangladesh